TORONTO, August 17, 2021 – Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTCQB: RYMDF, Frankfurt: EIY2) is pleased to announce the strategic appointments of Mr. Chris Blask to the position of Vice President of Strategy, and Mr. Vadim Kositsky to Vice President of Artificial Intelligence and Data Science, strengthening the technical and executive leadership of the Company.
The appointments of Mr. Blask and Mr. Kositsky are critical to the advancement of the Company’s strategic initiatives related to IoT security, Data sciences and Artificial Intelligence. Both appointments are effective immediately.
As VP Strategy, Mr. Blask will support the development and execution of the Company’s strategic direction and play an active role in implementing operations-oriented value creation opportunities across Relay’s technologies and product lines. VP of Artificial Intelligence and Data Science, Mr. Kositsky will lead the evolution of the Company’s focus on applying artificial intelligence and machine learning throughout Relay’s products.
“On behalf of the Company I’d like to welcome Chris and Vadim to their respective positions of VP Strategy and VP AI and Data Science,” said Yoav Raiter, CEO, Relay Medical Corp. “Originally joining as a Strategic Advisor to the Company, we are pleased to invite Chris to this key executive position. He will be an invaluable resource as we expand the market reach of our Cybeats integrated cybersecurity platform, as well as other Company business and technical initiatives. Vadim will lead the strategic implementation of AI, machine learning and data sciences which is a critical focus for our Company. Enlisting this executive strength is an exciting milestone and adds momentum to our current phase of growth.”
Chris Blask, VP Strategy
Mr. Blask is a seasoned global cybersecurity executive with nearly 30 years of experience in the cybersecurity industry. He has held executive positions with leading technology companies such as Unisys and Cisco Systems and has advised public and private organizations in every sector around the world. In his role at the Office of Innovation at Unisys, Mr. Blask created and led the Operational Technology and IoT security practices, invented the Digital Bill of Materials (DBOM) structure, and established the Unisys Marine Living Research Center. He is also credited with building a multi-billion-dollar firewall business at Cisco, a well-renowned U.S cybersecurity icon.
Mr. Blask also chairs and is on the board of a number of non-profit cybersecurity organizations and contributes to a wide range of global security efforts. Follow Chris on his blog, twitter and on LinkedIn.
Vadim Kositsky, VP Artificial Intelligence & Data Science
Mr. Kositsky has over 15 years of senior level experience specializing in the development of innovative artificial intelligence projects in computer vision and machine learning and has extensive knowledge in AI, cloud-based data science, as well as android, R&D and software development.
Mr. Kositsky has worked in multidisciplinary fields including geophysics, ophthalmic optics, and medical diagnostics. Prior to joining Relay Medical in 2019, he was a lead developer at Fio Corporation, he worked as team lead, senior software and algorithms developer for the integration of motion and eye tracking and system image processing at Shamir Optical, and is formerly an algorithms developer for the Israeli Defense Forces and for the Navy, in the Hydrography branch. Mr. Kositsky has a MSc in Medical Physics from Tel Aviv University and a BA in Physics from Technion - Israel Institute of Technology.
About Relay Medical Corp.
Relay Medical is a technology innovator headquartered in Toronto, Canada focused on the development of novel technologies in the diagnostics, AI data science and IoT security sectors.
Forward-looking Information Cautionary Statement
Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company’s control. There are no assurances that the commercialization plans for the technology described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which filings are available at www.sedar.com